Skip to content

The effect of paravertebral block on the contralateral side: A prospective observational study in breast surgery

The effect of paravertebral block on the contralateral side: A prospective observational study in breast surgery - The effect of paravertebral block on the contralateral side: A prospective observational study in breast surgery

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000053100
Enrollment
48
Registered
2023-12-14
Start date
2023-12-14
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients undergoing breast surgery (unilateral total mastectomy) due to anticipated breast cancer

Interventions

Ultrasound-guided PVB with 15 mL of 0.75% ropivacaine near the 4th-5th thoracic spine on the operative side (low volume group). Ultrasound-guided PVB with 30 mL of 0.375% ropivacaine near the 4th-5th

Sponsors

Aidu Chuo Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients undergoing breast surgery (unilateral total mastectomy and/or axillary lymph node dissection) under general anesthesia at Aidu Chuo Hospital after December 2023 who meet all three of the following criteria. 1) 18 years of age or older 2) Scheduled to undergo general anesthesia, and an American Society of Anesthesiologists physical status classification of 1-3 3) Written consent for participation in the study has been obtained from the patient or the patient's family.

Exclusion criteria

Exclusion criteria: One of the following applies: (1) Bilateral surgery is planned (2) Weight less than 40 kg or BMI more than 30 kg/m2 (3) History of spontaneous pneumothorax (4) General contraindications to PVB (e.g., continued use of anticoagulants or antiplatelet agents) (5) Inability to report the extent of effect immediately after surgery due to delayed awakening, etc (6) Cases in which PVB was attempted but the drug was administered in a shallow layer, resulting in MTPB or ESPB (7) Patient has difficulty in communication due to cognitive decline, hearing loss, etc. (8) Patients with decreased sensation (e.g., after cerebral infarction) (9) Other patients who are judged to be incompatible by the anesthesiologist (e.g., patients with severe obstructive lung disease that could be fatal if pneumothorax occurs).

Design outcomes

Primary

MeasureTime frame
Sensory block area and sensory decline area of the skin of the chest wall on both sides

Secondary

MeasureTime frame
Sensory block area and decline area of bilateral chest wall skin between low and high volume groups

Countries

Japan

Contacts

Public ContactKeisuke Yoshida

Fukushima Medical University Department of Anesthesiology

kei-y7of@fmu.ac.jp0245471342

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026